Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence

J Jinna Ren (Department of General Dentistry II Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices Beijing China) T Tianjiao Chu (Shanghai Advanced Research Institute Chinese Academy of Sciences Shanghai P. R. China) B Bozhao Li S Suying Wu (CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center of Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China) Z Zhenlin Yang (Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering) G Gengtian Sun (School and Hospital of Stomatology Jilin University Changchun Jilin China) Z Zefang Lu (CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center of Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China) F Feilong Qi (CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center of Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China) F Feifan Wu (School of Mechanical Engineering, Xi'an Jiaotong University 1 , Xi'an, Shaanxi 710049,) Y Yue Peng (School of Environment) M Mengyao Li Y Yuliang Zhao (University of Chinese Academy of Sciences) G Guangjun Nie (CAS Center for Excellence in Nanoscience) Y Yuguang Wang S Suping Li

Abstract

Abstract The immune‐suppressive microenvironment and extensive tumor angiogenesis are key contributors to the high recurrence and mortality rates of oral squamous cell carcinoma (OSCC). To address these challenges, a personalized 3D‐printed anti‐tumor vaccine (3D‐Vax‐L) is developed that integrates whole tumor antigens from postoperative tissue lysates with the angiogenesis inhibitor, lenvatinib. This vaccine not only possesses inherent adjuvant properties but also mimics the functions of lymph nodes through its porous structure, facilitating the recruitment and maturation of immune cells. In vivo studies in OSCC animal models, including mice and rabbits, demonstrate that 3D‐Vax‐L effectively recruits and matures immune cells at postoperative sites, inhibits angiogenesis and tumor recurrence, and extends survival time, all while maintaining a stable morphology and an excellent biosafety. Furthermore, 3D‐Vax‐L supports facial integrity post‐surgery, addressing physical challenges by preventing collapse and reducing the risk of aesthetic‐related disorders. These findings suggest that 3D‐Vax‐L is a promising therapeutic technique for preventing post‐surgical OSCC relapse, particularly as it offers a new strategy for immune system activation and demonstrates significant potential for clinical translation.

Article Details

Volume / Issue Vol. 37, Issue 39
Published October 01, 2025
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (15)

J

Jinna Ren

Department of General Dentistry II Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices Beijing China

T

Tianjiao Chu

Shanghai Advanced Research Institute Chinese Academy of Sciences Shanghai P. R. China

B

Bozhao Li

S

Suying Wu

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center of Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China

Z

Zhenlin Yang

Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering

G

Gengtian Sun

School and Hospital of Stomatology Jilin University Changchun Jilin China

Z

Zefang Lu

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center of Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China

F

Feilong Qi

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center of Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China

F

Feifan Wu

School of Mechanical Engineering, Xi'an Jiaotong University 1 , Xi'an, Shaanxi 710049,

Y

Yue Peng

School of Environment

M

Mengyao Li

Y

Yuliang Zhao

University of Chinese Academy of Sciences

G

Guangjun Nie

CAS Center for Excellence in Nanoscience

Y

Yuguang Wang

S

Suping Li